| |
| | Genome Therapeutics, University of Southampton and Schering-Plough identify novel asthma gene |
 | | Waltham, Mass., Southampton, U.K. and Kenilworth, N.J., July 10, 2002 — In a study released today in the leading scientific journal Nature, researchers at Genome Therapeutics (Nasdaq: GENE), University of Southampton and Schering-Plough Corporation (NYSE: SGP) describe the identification of a specific susceptibility gene linked to asthma. |
 | | As part of an alliance with Schering-Plough, a leader in respiratory care, to develop therapies for asthma, researchers at Genome Therapeutics and University of Southampton amassed clinical information and biological samples from over 450 families that suffered from the disease. |
 | | The University of Southampton has an outstanding record of success in the provision of high-quality teaching across the range of university subjects, and is widely recognised for its leading-edge research and scholarship, its commitment to innovation in teaching and learning, and its support for business and industry through consultancy, research partnerships and technology transfer. |
| www.eurekalert.org /pub_releases/2002-07/fkh-gtu070802.php (1192 words) |
|